BM 130907
Latest Information Update: 08 May 1998
Price :
$50 *
At a glance
- Originator Roche
- Class Antihyperglycaemics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 24 Nov 1994 Discontinued-I for Diabetes mellitus in Germany (Unknown route)